BMS, Roche announce joint cancer study; Canada blesses AZ's new heart drug;

@FiercePharma: Novartis scouts bolt-on deals of up to $3B. Article | Follow @FiercePharma

> Bristol-Myers Squibb and Roche said they would evaluate their respective cancer drugs in combination to treat a type of metastatic melanoma. Report

> Canadian regulators approved AstraZeneca's key new heart drug Brilinta, a boost for a product whose future in the all-important U.S. market is still uncertain. News

> Health experts said an unusually lethal strain of E. coli, which has infected more than 1,500 in Germany, was a previously unknown drug-resistant variant of the bacteria. Article

> A sharp rise in a type of throat cancer among men is increasingly being linked to HPV, the sexually transmitted human papillomavirus that can cause cervical cancer in women. Report

> Scientists say they are one step closer to establishing a way to double the U.S. supply of flu vaccine, thus warding off the possibility of shortages. Report

Biotech News

@FierceBiotech: J&J dumps $625M diabetes drug pact with Diamyd. Item | Follow @FierceBiotech

@JohnCFierce: Silenor has to be one of the lamest new products I've seen in recent times. | Follow @JohnCFierce

> Clovis teams with Roche on companion diagnostic for covalent cancer drug. Item 

> Merck CEO Frazier stands by his $8B R&D gamble. News

> Ziopharm vows to wow cancer field with synthetic biology drugs. Story

> UK pharma czar sees new "innovation ecosystem" R&D model emerge. Article

> GSK, Theravance report Ph3 successes for COPD treatment. Report

> BMS, Roche join forces and drugs on combo melanoma program. Item 

Vaccines News

> Lymphoma vaccine extends survival in late-stage study. News 

> MediGene, Johns Hopkins join on HPV vax research. Report 

> GAVI board hit with conflict of interest woes. Item 

> Intercell recalls encephalitis vaccine batch. Story 

Manufacturing News

> Congress queries ICE over 2008 heparin contamination. Report

> Unicef price postings aim for lower-cost vaccines. Story

> DHL bolsters cold chain with Sentry sensor device. Item

> FDA-TRACK update shows jump in FOIA requests. Story 

> Sanofi dictates contractor choice, re-org to Genzyme. Article 

> FDA: 5 recalls traced to excipients in 2010. News

And Finally... Why aren't there more Wall Street whistleblowers? Ask David Maris, the former Bank of America analyst who first questioned a 2003 Biovail quarterly report later investigated by the Securities & Exchange Commission. Report

Suggested Articles

German viral vector CDMO Vibalogics has hired Lonza veteran Tom Hochuli as global CEO to help lead its U.S. expansion efforts.

Merck’s Keytruda already boasts an OK in some esophageal cancer patients, but it’s looking to widen its reach in the tough-to-treat disease.

GI cancers are stubborn, as plenty of oncology drugmakers know. But BMS' Opdivo has broken through with two potentially practice-changing trials.